Advanced Bionics (AB), a global leader in cochlear implant technology and a company of the Sonova Group, announced today that their next-generation behind-the-ear sound processor is awaiting regulatory approval. Recipients in the United States, Canada and Europe who choose AB now will have the option to select the next processor and hear with the latest technology when it is available. Under the Sonova Group, Advanced Bionics collaborates with Phonak, bringing together the most advanced cochlear implant and hearing instrument innovations into one family. Designed for improved hearing in a wide variety of listening settings, the all-new processor will feature state-of-the-art technologies and accessories available exclusively from Advanced Bionics and Phonak for the first time in the market’s history. The new processor will be sized 40% smaller than AB’s current behind-the-ear processor, provide unprecedented performance capabilities and offer industry-leading wireless connectivity options. “We realize there is huge anticipation for AB to introduce the next-generation processor. Choosing AB now gives recipients in the U.S., Canada and Europe the option to enjoy the most advanced technology when it’s introduced,” said Hansjuerg Emch, Group Vice President of the Sonova Medical Division within which AB resides. “AB is known for industry firsts. With technology from AB and Phonak combined, the next processor to come from us will be history making for the market.” AB offers one of the world’s most sophisticated cochlear implant technologies to deliver clearer, high-resolution sound to those affected by significant hearing loss. The last year has been monumental for AB with the launch of Neptune™, the world’s first and only swimmable sound processor, and ClearVoice™*, the industry’s only sound processing strategy clinically proven to deliver superior performance. For more information about Advanced Bionics, contact a local AB representative or visit AdvancedBionics.com. About Advanced Bionics Advanced Bionics is a global leader in developing the most advanced cochlear implant systems in the world. Founded in 1993 and a subsidiary of the Sonova Group since 2009, AB develops cutting-edge cochlear implant technology that allows recipients to hear their best. AB offers the most sophisticated cochlear implant system on the market, the HiResolution™ Bionic Ear System, with five times more sound resolution than its competitors, designed to help recipients hear in noisy settings and enjoy the full dimensions of music.
With sales in over 50 countries and a proven track record for developing high-performing, state-of-the-art products, AB’s talented group of technologists and professionals from all over the world are driven to succeed, work with integrity and stay firmly committed to quality.To learn more about AB and its innovative cochlear implant technology, please visit AdvancedBionics.com. *Not approved for pediatric patients in the United States.